We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

woensdag 6 december 2017

British Journal of Cancer - Table of Contents alert Volume 117 Issue 12

If you are unable to see the message below, click here to view.
British Journal of Cancer
TABLE OF CONTENTS

Volume 117, Issue 12 (1733-1887)
Published online 5 December 2017
 

In this issue
Editorial
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Epidemiology

Also new today
Advance online publication
Digital Edition
 
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Editorial

Top

IGF-1R: SUMO-ing its weight in chemoresistant colorectal cancer

Ajay Goel

Br J Cancer 2017 117: 1733-1735; advance online publication, November 9, 2017; 10.1038/bjc.2017.377

Full Text

Minireview

Top

Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?

Alexander H Staudacher and Michael P Brown

Br J Cancer 2017 117: 1736-1742; advance online publication, October 24, 2017; 10.1038/bjc.2017.367

Abstract | Full Text

Clinical Studies

Top

Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review

A Prawira, S F Oosting, T W Chen, K A delos Santos, R Saluja, L Wang, L L Siu, K K W Chan and A R Hansen

Br J Cancer 2017 117: 1743-1752; advance online publication, October 24, 2017; 10.1038/bjc.2017.357

Abstract | Full Text

Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer

An Na Seo, Byung Woog Kang, Oh Kyoung Kwon, Ki Bum Park, Seung Soo Lee, Ho Young Chung, Wansik Yu, Han Ik Bae, Seong Woo Jeon, Hyojeung Kang and Jong Gwang Kim

Br J Cancer 2017 117: 1753-1760; advance online publication, October 26, 2017; 10.1038/bjc.2017.369

Abstract | Full Text

Liver transplant recipients have a higher prevalence of anal squamous intraepithelial lesions

A Albuquerque, H Pessegueiro Miranda, J Lopes, J Gandara, S Rodrigues, R Gaspar, R Morais, R Ramalho, E Rodrigues-Pinto, H Cardoso, H Barroca, C C Dias, F Carneiro and G Macedo

Br J Cancer 2017 117: 1761-1767; advance online publication, October 31, 2017; 10.1038/bjc.2017.370

Abstract | Full Text

Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials

Kaitlyn K H Goey, Sjoerd G Elias, Axel Hinke, Martijn G H van Oijen, Cornelis J A Punt, Susanna Hegewisch-Becker, Dirk Arnold and Miriam Koopman

Br J Cancer 2017 117: 1768-1776; advance online publication, November 9, 2017; 10.1038/bjc.2017.382

Abstract | Full Text

Translational Therapeutics

Top

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

Jordi Codony-Servat, Miriam Cuatrecasas, Elena Asensio, Carla Montironi, Anna Martínez-Cardús, Mercedes Marín-Aguilera, Carlos Horndler, Eva Martínez-Balibrea, Michele Rubini, Pedro Jares, Oscar Reig, Iván Victoria, Lydia Gaba, Marta Martín-Richard, Vicente Alonso, Pilar Escudero, Carlos Fernández-Martos, Jaime Feliu, Jose Carlos Méndez, Miguel Méndez, Javier Gallego, Antonieta Salud, Federico Rojo, Antoni Castells, Aleix Prat, Rafael Rosell, Xabier García-Albéniz, Jordi Camps and Joan Maurel

Br J Cancer 2017 117: 1777-1786; advance online publication, November 9, 2017; 10.1038/bjc.2017.279

Abstract | Full Text

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma

Carmela Dantas-Barbosa, Tom Lesluyes, François Le Loarer, Fréderic Chibon, Isabelle Treilleux, Jean-Michel Coindre, Pierre Meeus, Mehdi Brahmi, Olivia Bally, Isabelle Ray-Coquard, Marie-Pierre Sunyach, Axel Le Cesne, Olivier Mir, Sylvie Bonvalot, Maud Toulmonde, Antoine Italiano, Pierre Saintigny, Myriam Jean-Denis, Francoise Ducimetiere, Dominique Ranchere, Hiba El Sayadi, Laurent Alberti and Jean-Yves Blay

Br J Cancer 2017 117: 1787-1797; advance online publication, October 12, 2017; 10.1038/bjc.2017.354

Abstract | Full Text

ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer

Ikhyun Jun, Hyung Soon Park, He Piao, Jung Woo Han, Min Ji An, Byeong Gyu Yun, Xianglan Zhang, Yong Hoon Cha, You Keun Shin, Jong In Yook, Jinsei Jung, Heon Yung Gee, Joon Seong Park, Dong Sup Yoon, Hei-Cheul Jeung and Min Goo Lee

Br J Cancer 2017 117: 1798-1809; advance online publication, October 12, 2017; 10.1038/bjc.2017.355

Abstract | Full Text

Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma

Woo Jin Bae, Bon Seok Koo, Sang Hyuk Lee, Jin Man Kim, Young Soo Rho, Jae Yol Lim, Jung Hwa Moon, Jae Hoon Cho and Young Chang Lim

Br J Cancer 2017 117: 1810-1818; advance online publication, November 2, 2017; 10.1038/bjc.2017.373

Abstract | Full Text

Molecular Diagnostics

Top

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma

Astrid Lièvre, Bérèngere Ouine, Jim Canet, Aurélie Cartier, Yael Amar, Wulfran Cacheux, Odette Mariani, Rosine Guimbaud, Janick Selves, Thierry Lecomte, Serge Guyetant, Ivan Bieche, Frédérique Berger and Leanne de Koning

Br J Cancer 2017 117: 1819-1827; advance online publication, October 12, 2017; 10.1038/bjc.2017.353

Abstract | Full Text

Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion

Ching-Fang Yu, Fang-Hsin Chen, Meng-Hsuan Lu, Ji-Hong Hong and Chi-Shiun Chiang

Br J Cancer 2017 117: 1828-1836; advance online publication, October 24, 2017; 10.1038/bjc.2017.362

Abstract | Full Text

CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma

Thomas A Werner, Christina M Forster, Levent Dizdar, Pablo E Verde, Katharina Raba, Matthias Schott, Wolfram T Knoefel and Andreas Krieg

Br J Cancer 2017 117: 1837-1845; advance online publication, November 7, 2017; 10.1038/bjc.2017.364

Abstract | Full Text

A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline

Xiaohui Liu, Weimin Zheng, Wansheng Wang, Huali Shen, Linxiao Liu, Wenhui Lou, Xiaolin Wang and Pengyuan Yang

Br J Cancer 2017 117: 1846-1854; advance online publication, November 9, 2017; 10.1038/bjc.2017.365

Abstract | Full Text

Genetics & Genomics

Top

Global metabolomic profiling of uterine leiomyomas

Hanna-Riikka Heinonen, Miika Mehine, Netta Mäkinen, Annukka Pasanen, Esa Pitkänen, Auli Karhu, Nanna S Sarvilinna, Jari Sjöberg, Oskari Heikinheimo, Ralf Bützow, Lauri A Aaltonen and Eevi Kaasinen

Br J Cancer 2017 117: 1855-1864; advance online publication, October 26, 2017; 10.1038/bjc.2017.361

Abstract | Full Text

Epidemiology

Top

Cancer incidence in English children, adolescents and young people: past trends and projections to 2030

Francesca Pesola, Jacques Ferlay and Peter Sasieni

Br J Cancer 2017 117: 1865-1873; advance online publication, November 2, 2017; 10.1038/bjc.2017.341

Abstract | Full Text

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival

Vicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, Margaret M Kozak, Justin L Bui, Chen Yuan, Zhi Rong Qian, Ana Babic, Annacarolina Da Silva, Jonathan A Nowak, Natalia Khalaf, Lauren K Brais, Marisa W Welch, Caitlin L Zellers, Kimmie Ng, Daniel T Chang, Rebecca A Miksad, Andrea J Bullock, Jennifer F Tseng, Richard S Swanson, Thomas E Clancy, David C Linehan, Jennifer J Findeis-Hosey, Leona A Doyle, Jason L Hornick, Shuji Ogino, Charles S Fuchs, Aram F Hezel, Albert C Koong and Brian M Wolpin

Br J Cancer 2017 117: 1874-1882; advance online publication, October 5, 2017; 10.1038/bjc.2017.349

Abstract | Full Text

30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure

Wan-Hua Hsieh, I-Feng Lin, Jung-Chun Ho and Peter Wushou Chang

Br J Cancer 2017 117: 1883-1887; advance online publication, October 3, 2017; 10.1038/bjc.2017.350

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature